Long-term follow-up and exploratory analysis of lenvatinib in patients with metastatic or recurrent thymic carcinoma: Results from the multicenter, phase 2 REMORA trial

Authors:

Abstract
No abstract available
Funding Information
  • Eisai Canada
  • Japan Medical Association Center for Clinical Trials

This publication has 28 references indexed in Scilit: